483
Ortho-Clinical Diagnostics, Inc.FDA 483 - Ortho-Clinical Diagnostics, Inc. - May 10, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ortho Clinical Diagnostics in Rochester, NY, from April 29 to May 10, 2019, revealed a significant quality system deficiency. The firm failed to adequately establish corrective and preventive action (CAPA) procedures. Specifically, no CAPA was created to address the root cause of a product recall initiated in October 2018 for VITROS analyzer systems, indicating a breakdown in their post-market surveillance and quality control processes.
Open in Dashboard
ID · a63460f5-24d0-407b-ab3a-1a74a1013bc5